Alembic Pharma's Q3FY24 Quarter Results
Alembic Pharma’s revenues grew 8% YoY
- 05 Feb 2024
- Alembic Pharma reported 2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended December (Q3FY24). On a year-on-year (YoY) basis, it witnessed a growth of 8%.
- Its expenses for the quarter were down by 1% QoQ and up 8% YoY.
- The net profit grew 32% QoQ and 48% YoY.
- The earnings per share (EPS) of Alembic Pharma stood at 9.2 during Q3FY24.
Alembic Pharma’s Financial Statements for Q3FY24:
(Rs crores)
Total income
Q3FY23
1,509
Q2FY24
1,605
Q3FY24
1,633
QoQ (%)
2%
YoY (%)
8%
(Rs crores)
Total expenses
Q3FY23
1,341
Q2FY24
1,470
Q3FY24
1,449
QoQ (%)
-1%
YoY (%)
8%
(Rs crores)
Profit before tax
Q3FY23
154
Q2FY24
135
Q3FY24
185
QoQ (%)
37%
YoY (%)
19%
(Rs crores)
Tax
Q3FY23
33
Q2FY24
-2
Q3FY24
4
QoQ (%)
-
YoY (%)
-87%
(Rs crores)
Profit after tax
Q3FY23
122
Q2FY24
137
Q3FY24
180
QoQ (%)
32%
YoY (%)
48%
(Rs crores)
Earnings per share
Q3FY23
6.2
Q2FY24
7.0
Q3FY24
9.2
QoQ (%)
YoY (%)
| (Rs crores) | Q3FY23 | Q2FY24 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
| Total income | 1,509 | 1,605 | 1,633 | 2% | 8% |
| Total expenses | 1,341 | 1,470 | 1,449 | -1% | 8% |
| Profit before tax | 154 | 135 | 185 | 37% | 19% |
| Tax | 33 | -2 | 4 | - | -87% |
| Profit after tax | 122 | 137 | 180 | 32% | 48% |
| Earnings per share | 6.2 | 7.0 | 9.2 |
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Open Demat Account
or Resume your Application
